Bevacizumab in high-grade gliomas: past, present, and future.

Bevacizumab in high-grade gliomas: past, present, and future.

Item
http://www.wikidata.org/entity/Q38386873
How to train glioma cells to die: molecular challenges in cell death.Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma CellLong Non-coding RNA XIST Promotes Glioma Tumorigenicity and Angiogenesis by Acting as a Molecular Sponge of miR-429.Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer.Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials.Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.Long non-coding RNA HOTAIR enhances angiogenesis by induction of VEGFA expression in glioma cells and transmission to endothelial cells via glioma cell derived-extracellular vesicles.
P2860

Bevacizumab in high-grade gliomas: past, present, and future.

Item
http://www.wikidata.org/entity/Q38386873
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Bevacizumab in high-grade gliomas: past, present, and future.
@en
type
label
Bevacizumab in high-grade gliomas: past, present, and future.
@en
prefLabel
Bevacizumab in high-grade gliomas: past, present, and future.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Bevacizumab in high-grade gliomas: past, present, and future.
@en
P2093
P2860
P304
P31
P356
10.1586/14737140.2015.1028376
P433
P478
P577
P698
P921